Coya Therapeutics (COYA) announced that it has entered into definitive securities purchase agreements for the purchase and sale of an aggregate of 1.379M shares of its common stock in a private placement at a price of $7.25 per share. The offering is expected to close on or about October 23, subject to the satisfaction of customary closing conditions. The majority of investors in the offering are existing institutional stockholders of the company. The gross proceeds to the company from the private placement are expected to be approximately $10M, before deducting the placement agents’ fees and other offering expenses payable by the company. The company intends to use the net proceeds for general corporate purposes, including general and administrative expenses, working capital and to support preclinical, clinical and regulatory activities related to the company’s existing and future product candidate pipeline.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on COYA:
- Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
- Coya Therapeutics initiated with a Buy at H.C. Wainwright
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
